Bradley G Wagner
Overview
Explore the profile of Bradley G Wagner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
826
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Selvaraj P, Wagner B, Chao D, LAzou Jackson M, Breugelmans J, Jackson N, et al.
PLOS Glob Public Health
. 2023 Mar;
2(1):e0000053.
PMID: 36962090
How COVID-19 vaccine is distributed within low- and middle-income countries has received little attention outside of equity or logistical concerns but may ultimately affect campaign impact in terms of infections,...
2.
Kerr C, Stuart R, Mistry D, Abeysuriya R, Rosenfeld K, Hart G, et al.
PLoS Comput Biol
. 2021 Jul;
17(7):e1009149.
PMID: 34310589
The COVID-19 pandemic has created an urgent need for models that can project epidemic trends, explore intervention scenarios, and estimate resource needs. Here we describe the methodology of Covasim (COVID-19...
3.
Wagner B, Althouse B, Givon-Lavi N, Hu H, Dagan R
Vaccine
. 2019 Aug;
37(37):5625-5629.
PMID: 31383489
Streptococcus pneumoniae (SP) nasopharyngeal carriage studies are important to understand SP circulation prior to implementation of vaccination programs. It is generally not known how stable these carriage rates are over...
4.
Chang S, Chihota V, Fielding K, Grant A, Houben R, White R, et al.
BMC Med
. 2018 Dec;
16(1):242.
PMID: 30591052
The original article [1] did not contain comprehensive information regarding two authors' affiliations that may be considered a potential competing interest.
5.
Bershteyn A, Gerardin J, Bridenbecker D, Lorton C, Bloedow J, Baker R, et al.
Pathog Dis
. 2018 Jul;
76(5).
PMID: 29986020
Individual-based models provide modularity and structural flexibility necessary for modeling of infectious diseases at the within-host and population levels, but are challenging to implement. Levels of complexity can exceed the...
6.
Chang S, Chihota V, Fielding K, Grant A, Houben R, White R, et al.
BMC Med
. 2018 Apr;
16(1):52.
PMID: 29642897
Background: Gold mines represent a potential hotspot for Mycobacterium tuberculosis (Mtb) transmission and may be exacerbating the tuberculosis (TB) epidemic in South Africa. However, the presence of multiple factors complicates...
7.
Menzies N, Gomez G, Bozzani F, Chatterjee S, Foster N, Baena I, et al.
Lancet Glob Health
. 2016 Oct;
4(11):e816-e826.
PMID: 27720689
Background: The post-2015 End TB Strategy sets global targets of reducing tuberculosis incidence by 50% and mortality by 75% by 2025. We aimed to assess resource requirements and cost-effectiveness of...
8.
Houben R, Menzies N, Sumner T, Huynh G, Arinaminpathy N, Goldhaber-Fiebert J, et al.
Lancet Glob Health
. 2016 Oct;
4(11):e806-e815.
PMID: 27720688
Background: The post-2015 End TB Strategy proposes targets of 50% reduction in tuberculosis incidence and 75% reduction in mortality from tuberculosis by 2025. We aimed to assess whether these targets...
9.
Huynh G, Klein D, Chin D, Wagner B, Eckhoff P, Liu R, et al.
BMC Med
. 2015 Apr;
13:88.
PMID: 25896465
Background: In the last 20 years, China ramped up a DOTS (directly observed treatment, short-course)-based tuberculosis (TB) control program with 80% population coverage, achieving the 2015 Millennium Development Goal of...
10.
Gerberry D, Wagner B, Garcia-Lerma J, Heneine W, Blower S
Nat Commun
. 2014 Dec;
5:5454.
PMID: 25462707
Antiretroviral (ARV)-based pre-exposure HIV interventions may soon be rolled out in resource-constrained Sub-Saharan African countries, but rollout plans have yet to be designed. Here we use geospatial modelling and optimization...